| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5883009 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 6 Pages |
Abstract
We found differences in D-D serum levels and soluble uPAR between control participants and patients with lymphoma. These results indicate that D-D serum levels and soluble uPAR should be considered biomarkers of response and survival in patients with lymphoma.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
BenjamÃn Rubio-Jurado, Alejandra Tello-González, Lili Bustamante-Chávez, Aurora de la Peña, Carlos Riebeling-Navarro, Arnulfo Hernan Nava-Zavala,